Cisplatin

From WikiMD's Wellnesspedia

What is Cisplatin?[edit | edit source]

Cisplatin
Cisplatin 3D Structure

What are the uses of this medicine?[edit | edit source]

Cisplatin for injection is a platinum-based drug indicated for the treatment of:

How does this medicine work?[edit | edit source]

Cisplatin mechanism

  • Cisplatin (sis pla' tin) was the first chemotherapeutic agent of its subclass to be discovered.
  • It is an inorganic, water soluble complex containing a central platinum atom surrounded by 2 chlorine atoms and ammonia moieties in the cis position in the horizontal plane.
  • Cisplatin forms irreversible covalent links with DNA, causing cross linking of DNA chains as well as breaks in the DNA chain and missense mutations.
  • The DNA injury triggers cell death and inhibits RNA and protein synthesis, particularly in rapidly dividing cells.

Who Should Not Use this medicine ?[edit | edit source]

This medicine cannot be used in patients with:

What drug interactions can this medicine cause?[edit | edit source]

Avoid coadministration with:

Is this medicine FDA approved?[edit | edit source]

  • Cisplatin has activity against multiple tumor types and was approved for use by the United States in 1978.

How should this medicine be used?[edit | edit source]

  • Patients treated with cisplatin for injection must receive appropriate pre-treatment hydration.
  • Maintain adequate hydration and urinary output for 24 hours after cisplatin for injection administration.
  • Administer pre-treatment and post-treatment antiemetics as appropriate.

Recommended dosage: Advanced Testicular Cancer:

  • Cisplatin for injection has been administered at 20 mg/m2 intravenously daily for 5 days per cycle.
  • Other doses and combination regimens have been used.

Advanced Ovarian Cancer:

  • Cisplatin for injection has been administered at 75 mg/m2 to 100 mg/m2 intravenously per cycle once every 3 to 4 weeks on Day 1.
  • Other doses and combination regimens have been used.

Advanced Bladder Cancer:

  • Cisplatin for injection has been administered at 50 mg/m2 to 70 mg/m2 intravenously per cycle once every 3 to 4 weeks.
  • For heavily pretreated patients, an initial dose of 50 mg/m2 per cycle repeated every 4 weeks is recommended.
  • Other doses and combination in regimens have been used.

Administration:

  • Administer by slow intravenous infusion.
  • Avoid contact of cisplatin for injection with aluminum parts.

What are the dosage forms and brand names of this medicine?[edit | edit source]

This medicine is available in fallowing doasage form:

  • As Lyophilized powder: Single-dose vials containing 50 mg

This medicine is available in fallowing brand namesː

  • CISPLATIN injection

What side effects can this medication cause?[edit | edit source]

The most common side effects of this medicine include:

What special precautions should I follow?[edit | edit source]

  • cisplatin for injection can cause severe renal toxicity, including acute renal failure. Ensure adequate hydration. Consider dose reductions or alternative treatments in patients with renal impairment.
  • Cisplatin for injection can cause dose-related peripheral neuropathy that becomes more severe with repeated courses of the drug. Perform a neurological examination before initiating cisplatin for injection, at appropriate intervals during therapy, and after completion of therapy.
  • cisplatin for injection can cause severe nausea and vomiting. Premedicate with antiemetics.
  • cisplatin for injection can cause severe myelosuppression with fatalities due to infections. Monitor blood counts and interrupt therapy accordingly.
  • Cisplatin for injection can cause severe hypersensitivity reactions, including anaphylaxis and death. Anaphylaxis and death may occur; monitor for and treat accordingly.
  • Cisplatin for injection can cause ototoxicity, which is cumulative and may be severe. Cumulative toxicity may be severe particularly in pediatric patients; consider audiometric and vestibular function monitoring.
  • Optic neuritis, papilledema, and cortical blindness have been reported in patients receiving standard recommended doses of cisplatin for injection.
  • The development of acute leukemia secondary to the use of cisplatin for injection has been reported.
  • Based on human data, cisplatin for injection can cause fetal harm when administered to a pregnant woman. Advise pregnant women and females of reproductive potential of the potential risk to a fetus. Advise male patients with female partners of reproductive potential to use effective contraception during treatment and for 11 months after the last dose of cisplatin for injection.
  • Injection site reactions can occur during the administration of cisplatin for injection. Because of the possibility of extravasation, closely monitor the infusion site during drug administration.

What to do in case of emergency/overdose?[edit | edit source]

Symptoms of overdosage may include:

Management of overdosage:

  • Management of overdosage should include general supportive measures to sustain the patient through any period of toxicity that may occur.
  • Important measures include renal protection by intravenous hydration with or without the use of an osmotic diuretic.
  • Hemodialysis is not effective because of the high degree of protein binding of cisplatin for injection.
  • Plasmapheresis has been used to treat cases of cisplatin for injection overdosage.

Can this medicine be used in pregnancy?[edit | edit source]

  • Based on human data from published literature, cisplatin for injection can cause fetal harm when administered to pregnant women.
  • Advise pregnant women and females of reproductive potential of the potential risk to a fetus.

Can this medicine be used in children?[edit | edit source]

  • Ototoxic effects may be more severe and detrimental in pediatric patients receiving cisplatin for injection, particularly in patients less than 5 years of age.

What are the active and inactive ingredients in this medicine?[edit | edit source]

Active ingredient:

  • cisplatin

Inactive ingredients:

  • Sodium Chloride
  • Mannitol
  • HYDROCHLORIC ACID

Who manufactures and distributes this medicine?[edit | edit source]

Manufactured for:

  • WG Critical Care, LLC
  • Paramus, NJ

What should I know about storage and disposal of this medication?[edit | edit source]

Storage:

  • Store at 20°C to 25°C (68°F to 77°F); excursions permitted to 15°C to 30°C (59°F to 86°F).
  • Prior to reconstitution, store in original carton to protect from light.
  • Discard unused portion.

Handling and Disposal:

  • Cisplatin for injection, USP is a cytotoxic drug.
  • Follow applicable special handling and disposal procedures.


Alphabetic list of antineoplastic agents - 0-9 - A1 - A2 - A3 - A4 - A5 -A6 - B - C - D - E - F - G - H - I - JK - L - M - NO - PQ - R - S - T - UVW - XYZ


Cisplatin Resources

Find a healthcare provider anywhere in the world quickly and easily!

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski

WikiMD.png


WikiMD is the world's largest, free medical and wellness encyclopedia edited only by professionals. Advertise!

Wiki.png

Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Search WikiMD


Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD

WikiMD is not a substitute for professional medical advice. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.